Actinium Pharmaceuticals Inc banner
A

Actinium Pharmaceuticals Inc
F:7AY1

Watchlist Manager
Actinium Pharmaceuticals Inc
F:7AY1
Watchlist
Price: 0.792 EUR -4.23%
Market Cap: €23.6m

Wall St Price Targets

7AY1 Price Targets Summary
Actinium Pharmaceuticals Inc

Wall Street analysts forecast 7AY1 stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for 7AY1 is 4.548 EUR with a low forecast of 2.457 EUR and a high forecast of 6.385 EUR.

Lowest Forecast
Price Target
2.457 EUR
210% Upside
Average Forecast
Price Target
4.548 EUR
474% Upside
Highest Forecast
Price Target
6.385 EUR
706% Upside
Actinium Pharmaceuticals Inc Competitors:
Price Targets
FLB
Fluidigm Corp
215% Upside
AFYA
Afya Ltd
20% Upside
AMAL
Amalgamated Bank
5% Upside

Revenue
Forecast

N/A
Past Growth
201% / Year
Estimated Growth
Estimates Accuracy
-28%
Average Miss
N/A
Past Growth
201% / Year
Estimated Growth
Estimates Accuracy
-28%
Average Miss

The compound annual growth rate for Revenue over the next 8 years is 201%.

Gross Profit
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-3%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Pre-Tax Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-2%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-1%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-1%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is 7AY1's stock price target?
Price Target
4.548 EUR

According to Wall Street analysts, the average 1-year price target for 7AY1 is 4.548 EUR with a low forecast of 2.457 EUR and a high forecast of 6.385 EUR.

What is the Revenue forecast for Actinium Pharmaceuticals Inc?
Projected CAGR
201%

The compound annual growth rate for Revenue over the next 8 years is 201%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett